Briefing: Trump Pushes Drug Pricing Policy Amid Biotech Developments
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Editorial Staff
1 min read
Updated 4 months ago
Trump's administration is focusing on drug pricing reforms.
Legislative text has been drafted and shared with pharmaceutical companies.
Chinese biotech licensing is also a topic of interest.